Journal article
Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?
S Kapur, AG Phillips, TR Insel
Molecular Psychiatry | NATURE PUBLISHING GROUP | Published : 2012
DOI: 10.1038/mp.2012.105
Grants
Awarded by MRC
Awarded by Innovative Medicines Initiative (IMI) grant NEWMEDS
Funding Acknowledgements
SK has received grant support from GSK and has served as consultant and/or speaker for AstraZeneca, Bioline, BMS-Otsuka, Eli Lilly, Janssen (J&J), Lundbeck, NeuroSearch, Pfizer, Roche, Servier and Solvay Wyeth. AGP serves on the Board of Allon Therapeutics Inc., and holds shares in this corporation. TI has no financial interests to disclose.We would like to thank Dr Bruce Cuthbert for his useful comments on an earlier version of this manuscript. SK's research related to the article is supported by G0701748/1 from the MRC and the Innovative Medicines Initiative (IMI) grant NEWMEDS, under Grant Agreement N8 115008. SK received salary support from the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London.